Structure |
Chemical Name |
CAS |
MF |
![(4S,6S)-6-[2-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetic Acid 1,1-Dimethylethyl Ester](/CAS/GIF/472967-95-6.gif) |
(4S,6S)-6-[2-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetic Acid 1,1-Dimethylethyl Ester |
472967-95-6 |
C40H47FN2O5 |
![6a-Methylprednisone 21-Acetate](/CAS/GIF/115321-98-7.gif) |
6a-Methylprednisone 21-Acetate |
115321-98-7 |
C24H30O6 |
![Aztreonam Amide](/CAS/GIF/1219444-93-5.gif) |
Aztreonam Amide |
1219444-93-5 |
C13H20N6O8S2 |
![N'-[(2Z)-Piperazin-2-ylidene]trifluoroacetohydrazide](/CAS/GIF/763105-70-0.gif) |
N'-[(2Z)-Piperazin-2-ylidene]trifluoroacetohydrazide |
763105-70-0 |
C6H9F3N4O |
![BROMOSULBACTAM](/CAS/GIF/75527-87-6.gif) |
BROMOSULBACTAM |
75527-87-6 |
C8H10BrNO5S |
![(S)-PYRROLIDINE-2-CARBONITRILE](/CAS/GIF/204387-53-1.gif) |
(S)-PYRROLIDINE-2-CARBONITRILE |
204387-53-1 |
C5H8N2 |
![1-(CHLOROACETYL)-L-PROLINE METHYL ESTER](/CAS/GIF/38074-72-5.gif) |
1-(CHLOROACETYL)-L-PROLINE METHYL ESTER |
38074-72-5 |
C8H12ClNO3 |
![1-(4-PIPERIDINYLCARBONYL)-4-PIPERIDINECARBOXYLIC ACID](/CAS/GIF/96053-48-4.gif) |
1-(4-PIPERIDINYLCARBONYL)-4-PIPERIDINECARBOXYLIC ACID |
96053-48-4 |
C12H20N2O3 |
![1-(3-PYRIDYL)ETHAN-1-ONE OXIME](/CAS/GIF/5973-83-1.gif) |
1-(3-PYRIDYL)ETHAN-1-ONE OXIME |
5973-83-1 |
C7H8N2O |
![1-(3,4,5-Trimethoxy-benzyl)-piperazinedihydrochloride](/CAS/20150408/GIF/107049-57-0.gif) |
1-(3,4,5-Trimethoxy-benzyl)-piperazinedihydrochloride |
107049-57-0 |
C14H24Cl2N2O3 |
![Sitagliptin N-Sulfate](/CAS/GIF/940002-57-3.gif) |
Sitagliptin N-Sulfate |
940002-57-3 |
C16H15F6N5O4S |
![1-Oxo Mirtazapine (Mirtazapine Impurity C)](/CAS/GIF/191546-96-0.gif) |
1-Oxo Mirtazapine (Mirtazapine Impurity C) |
191546-96-0 |
C17H17N3O |
![N-(2,6-Dimethylphenyl)-2-(ethylmethylamino)acetamide Hydrochloride_x000b_(Lidocaine Impurity E)](/CAS2/GIF/50295-20-0.gif) |
N-(2,6-Dimethylphenyl)-2-(ethylmethylamino)acetamide Hydrochloride_x000b_(Lidocaine Impurity E) |
50295-20-0 |
C13H21ClN2O |
![ent-Cinacalcet Hydrochloride](/CAS/GIF/694495-47-1.gif) |
ent-Cinacalcet Hydrochloride |
694495-47-1 |
C22H22F3N |
![Nsc529487](/CAS/20180808/GIF/3310-47-2.gif) |
Nsc529487 |
3310-47-2 |
C9H13N3O6 |
![Oxathiolan 5fu-.B.](/CAS/GIF/145986-11-4.gif) |
Oxathiolan 5fu-.B. |
145986-11-4 |
C8H9FN2O4S |
![Decarboxy Enrofloxacin](/CAS/GIF/131775-99-0.gif) |
Decarboxy Enrofloxacin |
131775-99-0 |
C18H22FN3O |
![Desethanol Dipyridamole](/CAS/GIF/1176886-12-6.gif) |
Desethanol Dipyridamole |
1176886-12-6 |
C22H36N8O3 |
![2’’-Desethyl-2’’-vinyl Simvastatin](/CAS/20200611/GIF/1449248-72-9.gif) |
2’’-Desethyl-2’’-vinyl Simvastatin |
1449248-72-9 |
C25H36O5 |
![1,2-Dihydro Dexamethasone](/CAS/GIF/426-17-5.gif) |
1,2-Dihydro Dexamethasone |
426-17-5 |
C22H31FO5 |
![Lamotrigine N2-Oxide](/CAS/20200611/GIF/136565-76-9.gif) |
Lamotrigine N2-Oxide |
136565-76-9 |
C9H7Cl2N5O |
![4-[3-(Methylamino)-1-(2-thienyl)propyl]-](/CAS/GIF/949096-01-9.gif) |
4-[3-(Methylamino)-1-(2-thienyl)propyl]- |
949096-01-9 |
C18H20BrNOS |
![N-Isopropyl Carvedilol](/CAS/GIF/1246819-01-1.gif) |
N-Isopropyl Carvedilol |
1246819-01-1 |
C27H32N2O4 |
![5-Oxo Atorvastatin](/CAS/GIF/1391052-82-6.gif) |
5-Oxo Atorvastatin |
1391052-82-6 |
C33H33FN2O5 |
![1-Methyl-12-thioxopyrido[1,2,3,4]imidazole-[1,2-a]benzimidazole-2(12H)-one](/CAS/GIF/1246819-06-6.gif) |
1-Methyl-12-thioxopyrido[1,2,3,4]imidazole-[1,2-a]benzimidazole-2(12H)-one |
1246819-06-6 |
C14H9N3OS |
![Quetiapine Hydroxy Impurity](/CAS/20200611/GIF/329216-67-3.gif) |
Quetiapine Hydroxy Impurity |
329216-67-3 |
C19H21N3OS |
![7-[4-(2-Piperidinyl)ethoxy]benzoyl Raloxifene
(Raloxifene Impurity)](/CAS/GIF/1159977-58-8.gif) |
7-[4-(2-Piperidinyl)ethoxy]benzoyl Raloxifene
(Raloxifene Impurity) |
1159977-58-8 |
C42H44N2O6S |
![rac N-Demethyl Promethazine Hydrochloride](/CAS/GIF/60113-77-1.gif) |
rac N-Demethyl Promethazine Hydrochloride |
60113-77-1 |
C16H19ClN2S |
![Lincomycin B Hydrochloride](/CAS/20211123/GIF/11021-35-5.gif) |
Lincomycin B Hydrochloride |
11021-35-5 |
C17H33ClN2O6S |
![Flucloxacillin impurity C](/) |
Flucloxacillin impurity C |
|
|
![1-[2-amino-1-(4-hydroxyphenyl)ethyl]cyclohexanol](/CAS/GIF/149289-29-2.gif) |
1-[2-amino-1-(4-hydroxyphenyl)ethyl]cyclohexanol |
149289-29-2 |
C14H21NO2 |
![(2E)-3-(Dimethylamino)-1-(3-pyridyl)prop-2-en-1-one](/CAS2/GIF/123367-26-0.gif) |
(2E)-3-(Dimethylamino)-1-(3-pyridyl)prop-2-en-1-one |
123367-26-0 |
C10H12N2O |
![5-(2R)-2-Oxiranyl-8-benzyloxy-2(1H)-quinolinone](/CAS2/GIF/173140-90-4.gif) |
5-(2R)-2-Oxiranyl-8-benzyloxy-2(1H)-quinolinone |
173140-90-4 |
C18H15NO3 |
![3-Dechloro Sertraline Hydrochloride](/CAS/20150408/GIF/79646-00-7.gif) |
3-Dechloro Sertraline Hydrochloride |
79646-00-7 |
C17H19Cl2N |
![7-DeMethyl Ivabradine](/CAS/GIF/304462-60-0.gif) |
7-DeMethyl Ivabradine |
304462-60-0 |
C26H34N2O5 |
![8-Dechloro-9-chloro Loratadine](/CAS/GIF/109537-11-3.gif) |
8-Dechloro-9-chloro Loratadine |
109537-11-3 |
C22H23ClN2O2 |
![Acyclovir N-Ethyl-L-valinate Hydrochloride](/CAS/GIF/1346617-49-9.gif) |
Acyclovir N-Ethyl-L-valinate Hydrochloride |
1346617-49-9 |
C15H25ClN6O4 |
![AMikacin B](/CAS/GIF/48237-20-3.gif) |
AMikacin B |
48237-20-3 |
C22H44N6O12 |
![Carboxy Gliclazide](/CAS/GIF/38173-52-3.gif) |
Carboxy Gliclazide |
38173-52-3 |
C15H19N3O5S |
![Dehydro RifaxiMin](/CAS/GIF/80621-76-7.gif) |
Dehydro RifaxiMin |
80621-76-7 |
C43H49N3O11 |
![N,N'-Desethylene Levofloxacin Hydrochloride](/CAS/20140608/GIF/CB72543906.gif) |
N,N'-Desethylene Levofloxacin Hydrochloride |
151250-76-9 |
C16H18FN3O4 |
![rac 3-Deacetyl-3-butanoyl Acebutolol Hydrochloride](/CAS/GIF/57898-71-2.gif) |
rac 3-Deacetyl-3-butanoyl Acebutolol Hydrochloride |
57898-71-2 |
C20H33ClN2O4 |
![rac Deoxy-O-desMethyl Venlafaxine](/CAS/20140608/GIF/CB72544099.gif) |
rac Deoxy-O-desMethyl Venlafaxine |
1346605-18-2 |
C16H25NO |
![2-Keto ZolpideM](/CAS/20180808/GIF/400038-68-8.gif) |
2-Keto ZolpideM |
400038-68-8 |
C19H19N3O2 |
![N-ForMyl Oxcarbazepine](/CAS/GIF/1346601-76-0.gif) |
N-ForMyl Oxcarbazepine |
1346601-76-0 |
C16H12N2O3 |
![OseltaMivir Acid Methyl Ester](/CAS/GIF/208720-71-2.gif) |
OseltaMivir Acid Methyl Ester |
208720-71-2 |
C15H26N2O4 |
![2'-[(1E)-2-[4-[[(2-carboxyethyl)aMino]carbonyl]phenyl]diazenyl] Balsalazide](/CAS/20140608/GIF/CB72551435.gif) |
2'-[(1E)-2-[4-[[(2-carboxyethyl)aMino]carbonyl]phenyl]diazenyl] Balsalazide |
1346606-53-8 |
C27H24N6O9 |
![7β-Fulvestrant](/CAS/GIF/407577-53-1.gif) |
7β-Fulvestrant |
407577-53-1 |
C32H47F5O3S |
![1,3-Di-HABA KanaMycin A](/CAS/GIF/927821-99-6.gif) |
1,3-Di-HABA KanaMycin A |
927821-99-6 |
C26H50N6O15 |
![Dantrolene Related Compound B (50 mg) (5-(4-nitrophenyl)-2-furaldehyde-(2-carboxymethyl) semicarbazone)](/CAS/20150408/GIF/57268-33-4.gif) |
Dantrolene Related Compound B (50 mg) (5-(4-nitrophenyl)-2-furaldehyde-(2-carboxymethyl) semicarbazone) |
57268-33-4 |
C14H12N4O6 |
![Doxazosin Related Compound F (15 mg) (N,N'-bis(1,4-benzodioxane-2-carbonyl)piperazine)](/CAS/20150408/GIF/617677-53-9.gif) |
Doxazosin Related Compound F (15 mg) (N,N'-bis(1,4-benzodioxane-2-carbonyl)piperazine) |
617677-53-9 |
C22H22N2O6 |
![Verapamil Related Compound A (50 mg) (3,4-Dimethoxy-alpha-[3-(methylamino)propyl]-alpha-(1-methylethyl)-benzeneacetonitrile monohydrochloride)](/CAS/GIF/67775-97-7.gif) |
Verapamil Related Compound A (50 mg) (3,4-Dimethoxy-alpha-[3-(methylamino)propyl]-alpha-(1-methylethyl)-benzeneacetonitrile monohydrochloride) |
67775-97-7 |
C17H27ClN2O2 |
![Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1R,2S,4R)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-](/CAS/20150408/GIF/1255529-23-7.gif) |
Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1R,2S,4R)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]- |
1255529-23-7 |
C24H30ClN7O4S |
![Palonosetron](/CAS/GIF/135729-56-5.gif) |
Palonosetron |
135729-56-5 |
C19H22N2O |
![EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1R,2S,4S)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]-](/CAS/GIF/1255529-25-9.gif) |
EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1R,2S,4S)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]- |
1255529-25-9 |
C24H30ClN7O4S |
![N-((3R,4R)-1-benzyl-4-Methylpiperidin-3-yl)-2-chloro-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine](/CAS/20130318/GIF/CB72601888.gif) |
N-((3R,4R)-1-benzyl-4-Methylpiperidin-3-yl)-2-chloro-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine |
923036-25-3 |
C20H24ClN5 |
![8-Chloro-11-(piperidin-4-ylidene)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine](/CAS/20150408/GIF/117811-20-8.gif) |
8-Chloro-11-(piperidin-4-ylidene)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine |
117811-20-8 |
C19H17ClN2 |
![Fludarabine Phosphate iMpurity B](/CAS/20180808/GIF/149297-79-0.gif) |
Fludarabine Phosphate iMpurity B |
149297-79-0 |
C5H5N5O |
![nifedipine iMpurity C](/CAS/20130318/GIF/CB72610819.gif) |
nifedipine iMpurity C |
111304-31-5 |
C12H11NO5 |
![RofluMilast related substance](/CAS/GIF/475271-62-6.gif) |
RofluMilast related substance |
475271-62-6 |
C16H14Cl2N2O3 |
![Ritonavir EP Impurity I](/CAS/GIF/165315-26-4.gif) |
Ritonavir EP Impurity I |
165315-26-4 |
C36H46N6O5S2 |
![(6R-trans)-7-[(2,2-diMethyl-1-oxopropyl)aMino]-3-Methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-](/CAS/GIF/146794-70-9.gif) |
(6R-trans)-7-[(2,2-diMethyl-1-oxopropyl)aMino]-3-Methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2- |
146794-70-9 |
C13H18N2O4S |
![3-[3-[[[(7S)-3,4-DiMethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]Methyl]MethylaMino]propyl]-1,3-dihydro-7,8-diMethoxy-H-3-benzazepin-2-one](/CAS/GIF/1086026-31-4.gif) |
3-[3-[[[(7S)-3,4-DiMethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]Methyl]MethylaMino]propyl]-1,3-dihydro-7,8-diMethoxy-H-3-benzazepin-2-one |
1086026-31-4 |
C27H34N2O5 |
![7-[(3R)-3-[(N-Acetyl)AMino]-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoroMethyl)-1,2,4-triazolo[4,3-a]pyrazine](/CAS/20130318/GIF/CB72621905.gif) |
7-[(3R)-3-[(N-Acetyl)AMino]-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoroMethyl)-1,2,4-triazolo[4,3-a]pyrazine |
1379666-94-0 |
C18H17F6N5O2 |
![2-[[Methyl[(3S)-3-(1-naphthalenyloxy)-3-(2-thienyl)propyl]aMino]carbonyl]benzoic Acid](/CAS/GIF/199191-67-8.gif) |
2-[[Methyl[(3S)-3-(1-naphthalenyloxy)-3-(2-thienyl)propyl]aMino]carbonyl]benzoic Acid |
199191-67-8 |
C26H23NO4S |
![Labetalol IMpurity B](/CAS/20150408/GIF/802620-01-5.gif) |
Labetalol IMpurity B |
802620-01-5 |
C20H25NO4 |
![Ritonavir EP Impurity C](/CAS/GIF/1010808-43-1.gif) |
Ritonavir EP Impurity C |
1010808-43-1 |
C25H29N3O4S |
![AcetaMide, N,N-bis[2-(7-Methoxy-1-naphthalenyl)ethyl]-](/CAS/GIF/1385018-58-5.gif) |
AcetaMide, N,N-bis[2-(7-Methoxy-1-naphthalenyl)ethyl]- |
1385018-58-5 |
C28H29NO3 |
![(S)-quinuclidin-3-aMine](/CAS/GIF/120570-05-0.gif) |
(S)-quinuclidin-3-aMine |
120570-05-0 |
C7H14N2 |
![Benzene, 1-chloro-2-nitroso-](/CAS/GIF/932-33-2.gif) |
Benzene, 1-chloro-2-nitroso- |
932-33-2 |
C6H4ClNO |
![IMp. A (EP): Ethyl 4-[(11RS)-8-Chloro-11-hydroxy-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]piperidine-1-carboxylate](/CAS/20200611/GIF/38092-95-4.gif) |
IMp. A (EP): Ethyl 4-[(11RS)-8-Chloro-11-hydroxy-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]piperidine-1-carboxylate |
38092-95-4 |
C19H20N2 |
![PeMetrexed EP IMpurity E](/CAS/20180906/GIF/182009-04-7.gif) |
PeMetrexed EP IMpurity E |
182009-04-7 |
C20H21N5O6 |
![Itraconazole iMpurity A](/) |
Itraconazole iMpurity A |
|
|
![(S)-BoroLeu-(-)-Pinanediol-CF3COOH](/CAS/20180808/GIF/477254-69-6.gif) |
(S)-BoroLeu-(-)-Pinanediol-CF3COOH |
477254-69-6 |
C17H29BF3NO4 |
![Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, MonoMethyl ester](/CAS/GIF/3333-46-8.gif) |
Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, MonoMethyl ester |
3333-46-8 |
C5H8O6 |
![Valsartan D9](/CAS/GIF/1089736-73-1.gif) |
Valsartan D9 |
1089736-73-1 |
C24H29N5O3 |
![N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine](/CAS/GIF/1252883-90-1.gif) |
N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine |
1252883-90-1 |
C20H25N5 |
![P219490](/CAS/20180808/GIF/937370-10-0.gif) |
P219490 |
937370-10-0 |
C20H21N5Na2O6** |
![(S)-4-(TERT-BUTOXY)-2-ISOPROPYL-4-OXOBUTANOIC ACID](/CAS/20130318/GIF/CB72646658.gif) |
(S)-4-(TERT-BUTOXY)-2-ISOPROPYL-4-OXOBUTANOIC ACID |
134807-43-5 |
C11H20O4 |
![Acarbose D-Fructose IMpurity](/CAS/GIF/1013621-79-8.gif) |
Acarbose D-Fructose IMpurity |
1013621-79-8 |
C25H43NO18 |
![2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-(6-aMino-9H-purin-9-yl)-1-Methylethoxy]Methyl]-, 1-ethyl 9-(1-Methylethyl) ester, 5-oxide](/CAS/20180808/GIF/1422284-16-9.gif) |
2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-(6-aMino-9H-purin-9-yl)-1-Methylethoxy]Methyl]-, 1-ethyl 9-(1-Methylethyl) ester, 5-oxide |
1422284-16-9 |
C18H28N5O10P |
![(R)-α-[2-(1-naphthalenyloxy)ethyl]-benzeneMethanol](/CAS/20180808/GIF/156453-53-1.gif) |
(R)-α-[2-(1-naphthalenyloxy)ethyl]-benzeneMethanol |
156453-53-1 |
C19H18O2 |
![(1S,2S,3R,5S)-3-(7-((1S,2R)-2-(3,4-difluorophenyl)cyclopropylaMino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol](/CAS/20150408/GIF/CB72664140.gif) |
(1S,2S,3R,5S)-3-(7-((1S,2R)-2-(3,4-difluorophenyl)cyclopropylaMino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
2096989-56-7 |
C23H28F2N6O4S |
![Fosaprepitant iMpurity](/) |
Fosaprepitant iMpurity |
|
|
![Apixaban iMpurity 1](/) |
Apixaban iMpurity 1 |
|
|
![Azilsartan iMpurity H](/) |
Azilsartan iMpurity H |
|
|
![Azilsartan iMpurity M](/) |
Azilsartan iMpurity M |
|
|
![bortezoMib iMpurity F](/) |
bortezoMib iMpurity F |
|
|
![cefoxitin iMpurity A](/) |
cefoxitin iMpurity A |
|
|
![3-Morpholinone, 4-(2-aMinophenyl)-](/CAS/20150408/GIF/1082588-73-5.gif) |
3-Morpholinone, 4-(2-aMinophenyl)- |
1082588-73-5 |
C10H12N2O2 |
![(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(4-(trifluoroMethyl)phenyl)propan-1-aMine](/CAS/20150408/GIF/1428185-71-0.gif) |
(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(4-(trifluoroMethyl)phenyl)propan-1-aMine |
1428185-71-0 |
C22H22F3N |
![1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo-](/CAS/20180808/GIF/344418-92-4.gif) |
1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo- |
344418-92-4 |
C16H20N6O |
![Erlotinib impurity A](/CAS/20150408/GIF/183321-85-9.gif) |
Erlotinib impurity A |
183321-85-9 |
C21H20ClN3O3 |
![1,3-Dioxane-4,6-dione, 5-[[(3,4-diMethoxyphenyl)aMino]Methylene]-2,2-diMethyl-](/CAS/20150408/GIF/213699-53-7.gif) |
1,3-Dioxane-4,6-dione, 5-[[(3,4-diMethoxyphenyl)aMino]Methylene]-2,2-diMethyl- |
213699-53-7 |
C15H17NO6 |
![(2R,3R)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride](/CAS/20150408/GIF/1333998-21-2.gif) |
(2R,3R)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride |
1333998-21-2 |
C20H19ClF7NO2 |
![Budesonide iMpurity](/CAS/20180808/GIF/192057-49-1.gif) |
Budesonide iMpurity |
192057-49-1 |
C24H32O6 |
![dextroMethorphan iMpurity](/) |
dextroMethorphan iMpurity |
|
|
![Fluticasone IMpurity](/CAS/20150408/GIF/CB72669453.gif) |
Fluticasone IMpurity |
397864-58-3 |
C27H30F2O6S |
![Valdecoxib iMpurity](/) |
Valdecoxib iMpurity |
|
|
![Fluconazole IMpurity-H](/) |
Fluconazole IMpurity-H |
|
|